Timothy J. Richmond sold $6.1M of ABBV
EVP, CHIEF HR OFFICER at AbbVie Inc.. 29,917 shares at an average of $202.90, traded Feb 26, 2025, filed Feb 28, 2025.
Score components
- +15RoleOfficer
- +25Trade size$6.1M at market
- +20Share of holdings soldSold 58% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-006024, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2025 | SOpen-market sale Common stock, $0.01 par value10b5-1 | -1,400 | $202.06 | $283k | 50,591 | Feb 28, 2025 |
| Feb 26, 2025 | SOpen-market sale Common stock, $0.01 par value10b5-1 | -4,781 | $202.93 | $970k | 45,810 | Feb 28, 2025 |
| Feb 26, 2025 | SOpen-market sale Common stock, $0.01 par value10b5-1 | -1,526 | $203.64 | $311k | 44,284 | Feb 28, 2025 |
| Feb 26, 2025 | MOption exercise Common stock, $0.01 par value10b5-1 | +22,210 | $114.36 | $2.5M | 66,494 | Feb 28, 2025 |
| Feb 26, 2025 | SOpen-market sale Common stock, $0.01 par value10b5-1 | -4,308 | $201.97 | $870k | 62,186 | Feb 28, 2025 |
| Feb 26, 2025 | SOpen-market sale Common stock, $0.01 par value10b5-1 | -13,073 | $202.92 | $2.7M | 49,113 | Feb 28, 2025 |
| Feb 26, 2025 | SOpen-market sale Common stock, $0.01 par value10b5-1 | -4,829 | $203.63 | $983k | 44,284 | Feb 28, 2025 |
| Feb 26, 2025 | MOption exercise Option (Right to buy)derivative10b5-1 | -22,210 | $114.36 | $2.5M | 0 | Feb 28, 2025 |
Related signals
Other insiders at AbbVie Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | ABBVsell AbbVie Inc. | Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | $12M 58,832 shares | -52% | |
| 82Strong | AbbVie Inc. | Scott T Reents EVP, CHIEF FINANCIAL OFFICER | $3.7M 17,644 shares | -60% | |
| 40Moderate | AbbVie Inc. | Perry C Siatis EVP, GC AND SECRETARY | $5.8M 27,900 shares | -192% | |
| 60Notable | AbbVie Inc. | Richard A Gonzalez director | $20M 98,628 shares | -20% | |
| 55Moderate | AbbVie Inc. | Timothy J. Richmond EVP, CHIEF HR OFFICER | $4.5M 21,250 shares | -78% | |
| 70Notable | AbbVie Inc. | Kevin K Buckbee SVP, CONTROLLER | $3.9M 18,944 shares | -124% | |
| 40Moderate | AbbVie Inc. | Perry C Siatis EVP, GC AND SECRETARY | $1.1M 5,778 shares | -21% | |
| 19Weak | ABBVsell AbbVie Inc. | Kevin K Buckbee SVP, CONTROLLER | $310k 1,800 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.